Tiziana Life Sciences reversed into Alexander David Investments. Tiziana, which was formed last November, is being acquired for £7.5m in shares. Tiziana discovers and develops molecules with a focus on metastatic cancers, which are cancers that have spread to other parts of the body.
Sector: Health
Keep up to date with articles published at AIMMicro.com. Subscribe to AIM Micro RSS Feeds